Studies

On February 3, 2023, a train derailed in East Palestine, Ohio (EP), spilling multiple toxic chemicals from the derailed cars. On February 6, officials decided to “vent and burn” the chemicals, which greatly expanded both the number of toxic chemicals and the geographic reach of the toxic plume carried by prevailing winds. Many residents and first responders experienced a range of symptoms, prominently including irritant symptoms (burning eyes, nose, mouth, and skin), headaches, fatigue, bloody nose, and respiratory symptoms and conditions such as rhinitis, sinusitis, and new asthma.

The study aims to assess the mitigating toxic impact of Melatonin, Coenzyme Q10, and N-Acetylcysteine in Post-Exposure Protection.

This 6-week double-blinded trial examines whether individuals in the early stages of psychosis (EP) respond to 1000 mg of endocannabinoids (CBD) with the aim of improving positive, negative, and cognitive symptoms of psychosis.

The study aimed to evaluate the feasibility and explore the potential effects of using aromatherapy and visual mindfulness as complementary therapies to address pain and nausea in hospitalized cancer patients.

A randomized, double-blinded, placebo-controlled clinical trial to evaluate the safety of FoTv (a combination of two polypore mushrooms, Fomitopsis officinalis, and Trametes versicolor) in an adult population at the time of COVID-19 vaccination.

A multi-centered, randomized, double-blinded, placebo-controlled clinical trial to evaluate the safety of FoTv (a combination of two polypore mushrooms, Fomitopsis officinalis and Trametes versicolor) for COVID-positive outpatients with mild-to-moderate symptoms.

A multi-centered, randomized, double-blinded, placebo-controlled clinical trial to evaluate the safety of mQFPD as a modified form of Qing Fei Pai Du Tang (a Chinese herbal formula that has widely been used in Asia for COVID-positive outpatients with mild-to-moderate symptoms).

A 2-week study testing a daily flavanol supplement in patients over age 50 preparing for joint replacement. Includes blood draws, daily intake logs, and assessments of anti-inflammatory, cognitive, and recovery-related outcomes.

This feasibility study aimed to examine whether 12 weeks of magnesium supplementation (450 mg magnesium citrate 3x day with food) might increase cerebral blood flow and reduce the stiffness of the medium-sized arteries in the brain of obese patients with metabolic syndrome.